1. Home
  2. INSM vs AFG Comparison

INSM vs AFG Comparison

Compare INSM & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • AFG
  • Stock Information
  • Founded
  • INSM 1988
  • AFG 1872
  • Country
  • INSM United States
  • AFG United States
  • Employees
  • INSM N/A
  • AFG N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • AFG Property-Casualty Insurers
  • Sector
  • INSM Health Care
  • AFG Finance
  • Exchange
  • INSM Nasdaq
  • AFG Nasdaq
  • Market Cap
  • INSM 12.6B
  • AFG 10.3B
  • IPO Year
  • INSM 2000
  • AFG N/A
  • Fundamental
  • Price
  • INSM $67.23
  • AFG $122.00
  • Analyst Decision
  • INSM Strong Buy
  • AFG Hold
  • Analyst Count
  • INSM 16
  • AFG 4
  • Target Price
  • INSM $95.29
  • AFG $138.75
  • AVG Volume (30 Days)
  • INSM 2.6M
  • AFG 411.7K
  • Earning Date
  • INSM 05-08-2025
  • AFG 05-06-2025
  • Dividend Yield
  • INSM N/A
  • AFG 7.48%
  • EPS Growth
  • INSM N/A
  • AFG N/A
  • EPS
  • INSM N/A
  • AFG 9.52
  • Revenue
  • INSM $381,030,000.00
  • AFG $7,984,000,000.00
  • Revenue This Year
  • INSM $30.36
  • AFG N/A
  • Revenue Next Year
  • INSM $115.55
  • AFG $5.56
  • P/E Ratio
  • INSM N/A
  • AFG $12.80
  • Revenue Growth
  • INSM 20.77
  • AFG 4.76
  • 52 Week Low
  • INSM $21.92
  • AFG $114.73
  • 52 Week High
  • INSM $84.91
  • AFG $150.19
  • Technical
  • Relative Strength Index (RSI)
  • INSM 42.27
  • AFG 41.23
  • Support Level
  • INSM $63.81
  • AFG $121.64
  • Resistance Level
  • INSM $73.39
  • AFG $130.66
  • Average True Range (ATR)
  • INSM 2.56
  • AFG 2.59
  • MACD
  • INSM -0.33
  • AFG -0.71
  • Stochastic Oscillator
  • INSM 35.70
  • AFG 5.25

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About AFG American Financial Group Inc.

American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The company also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. The company's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.

Share on Social Networks: